Published in Cancer on March 01, 2009
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys (2014) 3.69
Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health (2012) 1.26
Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med (2015) 1.03
Triple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol (2011) 1.03
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Res Treat (2012) 0.99
Clinicopathological features and treatment strategy for triple-negative breast cancer. Int J Clin Oncol (2010) 0.92
Management options in triple-negative breast cancer. Breast Cancer (Auckl) (2011) 0.90
Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype. J Breast Cancer (2011) 0.87
Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy. J Korean Med Sci (2010) 0.84
The implications of breast cancer molecular phenotype for radiation oncology. Front Oncol (2011) 0.82
Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J (2014) 0.80
Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). Int J Radiat Oncol Biol Phys (2010) 0.79
HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World J Surg Oncol (2014) 0.79
Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy. Breast Cancer (Dove Med Press) (2014) 0.78
Triple Negative Breast Cancer versus Non-Triple Negative Breast Cancer Treated with Breast Conservation Surgery Followed by Radiotherapy: A Systematic Review and Meta-Analysis. Breast Care (Basel) (2015) 0.77
Chemotherapy response assay test and prognosis for breast cancer patients who have undergone anthracycline- and taxane-based chemotherapy. J Breast Cancer (2011) 0.77
Her2 positivity and race predict higher mastectomy rates: a SEER database analysis. Springerplus (2015) 0.76
New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast. Int Surg (2013) 0.75
Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women. Springerplus (2016) 0.75
Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer (2010) 0.75
Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes. Radiat Oncol J (2012) 0.75
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features. BMC Womens Health (2016) 0.75
Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype. Cureus (2016) 0.75
Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression. PLoS Genet (2017) 0.75
Unexpected features of breast cancer subtype. World J Surg Oncol (2015) 0.75
Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative. Oncotarget (2017) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 18.61
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res (2004) 16.51
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol (2006) 6.07
Basal-like breast cancer: a critical review. J Clin Oncol (2008) 5.64
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol (2008) 5.28
NIH consensus conference. Treatment of early-stage breast cancer. JAMA (1991) 4.35
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol (2001) 2.89
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol (2008) 2.85
Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol (2007) 2.20
Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg (1998) 1.29
Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol (2002) 0.92
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol (2011) 2.87
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst (2005) 2.10
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol (2005) 1.98
Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys (2008) 1.74
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys (2007) 1.71
Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol (2010) 1.52
Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type. Breast J (2015) 1.48
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen. Cancer (2006) 1.45
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol (2012) 1.45
Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol (2006) 1.45
A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: a predictor of nodal metastasis location. Cancer (2008) 1.41
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol (2009) 1.34
Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys (2008) 1.30
Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res (2011) 1.29
Double-balloon enteroscopy in the elderly: safety, findings, and diagnostic and therapeutic success. Gastrointest Endosc (2010) 1.21
Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys (2009) 1.14
Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes. Cancer (2004) 1.12
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.12
Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol (2008) 1.10
Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys (2005) 1.08
A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol (2009) 1.06
Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. Carcinogenesis (2007) 1.06
Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol (2007) 1.05
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. Mol Cancer Res (2012) 1.03
Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions. J Urol (2012) 1.01
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys (2007) 1.00
Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative. J Natl Compr Canc Netw (2007) 0.99
Primary small cell carcinoma of the vagina. Gynecol Oncol (2003) 0.98
Parent opinions regarding the genetic testing of minors for BRCA1/2. J Clin Oncol (2010) 0.96
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Int J Radiat Oncol Biol Phys (2008) 0.95
Intensity-modulated radiotherapy for early larynx cancer: is there a role? Int J Radiat Oncol Biol Phys (2007) 0.95
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys (2008) 0.95
Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int (2012) 0.94
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck (2010) 0.94
Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer (2003) 0.94
Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck (2011) 0.93
Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid (2013) 0.93
Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience. Int J Radiat Oncol Biol Phys (2012) 0.92
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcoma. Oncologist (2014) 0.91
Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth. Neoplasia (2012) 0.91
Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective. Clin Lung Cancer (2008) 0.91
Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol (2011) 0.91
Dynamic regulation of sarcoplasmic reticulum Ca(2+) stores by stromal interaction molecule 1 and sarcolipin during muscle differentiation. Dev Dyn (2012) 0.90
Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.90
A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol (2007) 0.90
Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant--is there a difference in complication rates? Int J Radiat Oncol Biol Phys (2008) 0.90
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors. Eur J Cancer (2010) 0.89
Selenium-containing 15-mer peptides with high glutathione peroxidase-like activity. J Biol Chem (2004) 0.89
Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy. J Urol (2012) 0.89
Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation. Breast J (2012) 0.89
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol (2012) 0.88
Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation. Am J Clin Oncol (2009) 0.88
Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol (2009) 0.87
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. Ann Surg Oncol (2012) 0.87
Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesions. J Invest Dermatol (2003) 0.86
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. Leuk Res (2013) 0.86
Parity confers better prognosis in older women with early-stage breast cancer treated with breast-conserving therapy. Clin Breast Cancer (2004) 0.86
History of smoking is associated with younger age at diagnosis of breast cancer. Breast J (2010) 0.86
Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.85
Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol (2007) 0.85
Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer. Gastrointest Cancer Res (2009) 0.85
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant. J Steroid Biochem Mol Biol (2006) 0.84
Genetics, the Big Five, and the tendency to be self-employed. J Appl Psychol (2010) 0.84
Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. Neoplasia (2013) 0.83
MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells. Cell Physiol Biochem (2013) 0.82
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck (2010) 0.82
Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation. Am J Surg (2013) 0.80
Intensity Modulated Radiation Therapy Reduces Gastrointestinal Toxicity in Patients Treated with Androgen Deprivation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys (2007) 0.80
Re-excision of margins before breast radiation-diagnostic or therapeutic? Int J Radiat Oncol Biol Phys (2006) 0.80
Importance of physical examination in the absence of a mammographic abnormality for the detection of early-stage breast cancer. Clin Breast Cancer (2005) 0.80
NHS-mediated QDs-peptide/protein conjugation and its application for cell labeling. Talanta (2008) 0.80
Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J (2014) 0.80
X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer. Int J Biol Markers (2015) 0.79
Selenium-platinum coordination compounds as novel anticancer drugs: selectively killing cancer cells via a reactive oxygen species (ROS)-mediated apoptosis route. Chem Asian J (2014) 0.79
RTK/ERK pathway under natural selection associated with prostate cancer. PLoS One (2013) 0.79
Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys (2010) 0.79
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma. J Gastrointest Cancer (2012) 0.79